Literature DB >> 17034947

Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.

Zheng Jiang1, Jin Hu, Xingang Li, Yuquan Jiang, Wei Zhou, Daru Lu.   

Abstract

DNA repair systems act to maintain genome integrity in the face of replication errors, environmental insults, and the cumulative effects of age. The mRNA expressions of 27 genes of the DNA repair system as well as their correlation with the clinical characteristics were studied in human astrocytoma. We applied TaqMan low-density array to investigate the mRNA expressions of 27 DNA repair genes in 40 astrocytoma tissues (10 of grade II, 10 of grade III, and 20 of grade IV, according to the WHO Grading System). And the normal brain tissues from 10 non-astrocytoma patients were collected as the control. In addition, correlation of their mRNA levels with clinical characteristics was also analyzed. We found that the expression of the 13 genes were significantly (P<0.01) down-regulated in grade II, III, IV of astrocytoma compared to normal brain tissues, including ERCC1, ERCC2, ERCC3, ERCC4, MGMT, MLH1, MLH3, NTHL1, OGG1, RAD50, SMUG1, XRCC4 and XRCC5. Meanwhile, we found that the expression of MSH2, MSH6, NUDT1 and XRCC3 were only significantly lower in grade II and III of astrocytoma, and the expression of MRE11A and MUS81 were only significantly lower in grade III and IV. But the expression of MPG, MSH3, MUTHY and RAD51 were not changed in any grade of astrocytoma. Furthermore, we found that the decrease expression of eight genes was significantly (P<0.05) associated with a poor prognosis, including ERCC3, ERCC4, MLH3, MRE11A, NTHL1, RAD50, XRCC4 and XRCC5. We suggest that TaqMan low-density array is an effective multivariate technique to examine the expression of DNA repair genes in astrocytomas, which can be applied to identify tumor-specific genes. We also suggest that the down-regulation of some DNA repair genes may be associated with pathogenesis and poor prognosis of astrocytoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034947     DOI: 10.1016/j.neulet.2006.09.038

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.

Authors:  Paul Eggleton; Lorna W Harries; Giada Alberigo; Paul Wordsworth; Nick Viner; Richard Haigh; Suzanne Donnelly; Hugh W Jones; Ian C Chikanza; Thomas W E O'Conner; Alasdair E R Thomson; Paul G Winyard
Journal:  J Clin Immunol       Date:  2010-06-09       Impact factor: 8.317

2.  PAC1 gene knockout reveals an essential role of chaperone-mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasis.

Authors:  Katsuhiro Sasaki; Jun Hamazaki; Masato Koike; Yuko Hirano; Masaaki Komatsu; Yasuo Uchiyama; Keiji Tanaka; Shigeo Murata
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

3.  Association of common KIBRA variants with episodic memory and AD risk.

Authors:  Jeremy D Burgess; Otto Pedraza; Neill R Graff-Radford; Meron Hirpa; Fanggeng Zou; Richard Miles; Thuy Nguyen; Ma Li; John A Lucas; Robert J Ivnik; Julia Crook; V Shane Pankratz; Dennis W Dickson; Ronald C Petersen; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  Neurobiol Aging       Date:  2010-12-24       Impact factor: 4.673

4.  The effects of HBx gene on the expression of DNA repair enzymes hOGG1 and hMYHalpha mRNA in HepG2 cells.

Authors:  Bin Cheng; Xiaorong Guo; Yaochu Zheng; Ying Wang; Chunyan Liu; Peiyuan Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

Review 5.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

6.  RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.

Authors:  Ulrica K Westermark; Nanna Lindberg; Pernilla Roswall; Daniel Bråsäter; Hildur R Helgadottir; Sanna-Maria Hede; Anders Zetterberg; Maria Jasin; Monica Nistér; Lene Uhrbom
Journal:  Neuro Oncol       Date:  2011-09-16       Impact factor: 12.300

7.  Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease.

Authors:  F Zou; M M Carrasquillo; V S Pankratz; O Belbin; K Morgan; M Allen; S L Wilcox; L Ma; L P Walker; N Kouri; J D Burgess; L H Younkin; Samuel G Younkin; C S Younkin; G D Bisceglio; J E Crook; D W Dickson; R C Petersen; N Graff-Radford; Steven G Younkin; N Ertekin-Taner
Journal:  Neurology       Date:  2010-02-09       Impact factor: 9.910

8.  DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.

Authors:  Preetha Rajaraman; Amy Hutchinson; Sara Wichner; Peter M Black; Howard A Fine; Jay S Loeffler; Robert G Selker; William R Shapiro; Nathaniel Rothman; Martha S Linet; Peter D Inskip
Journal:  Neuro Oncol       Date:  2009-12-10       Impact factor: 12.300

9.  Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer.

Authors:  Lise Aa Sørby; Solveig N Andersen; Ida R K Bukholm; Morten B Jacobsen
Journal:  J Exp Clin Cancer Res       Date:  2010-11-08

10.  Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.

Authors:  Paul A James; Ian G Campbell; Na Li; Magnus Zethoven; Simone McInerny; Lisa Devereux; Yu-Kuan Huang; Niko Thio; Dane Cheasley; Sara Gutiérrez-Enríquez; Alejandro Moles-Fernández; Orland Diez; Tu Nguyen-Dumont; Melissa C Southey; John L Hopper; Jacques Simard; Martine Dumont; Penny Soucy; Alfons Meindl; Rita Schmutzler; Marjanka K Schmidt; Muriel A Adank; Irene L Andrulis; Eric Hahnen; Christoph Engel; Fabienne Lesueur; Elodie Girard; Susan L Neuhausen; Elad Ziv; Jamie Allen; Douglas F Easton; Rodney J Scott; Kylie L Gorringe
Journal:  NPJ Breast Cancer       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.